# Fenretinide in Treating Patients With Cervical Neoplasia

> **NCT00003075** · PHASE3 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 39 (actual)

## Conditions studied

- Cervical Cancer
- Precancerous Condition

## Interventions

- **DRUG:** Fenretinide
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00003075
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1993-03-05
- **Primary completion:** 2001-05-01
- **Final completion:** 2001-05-01
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2018-10-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003075

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003075, "Fenretinide in Treating Patients With Cervical Neoplasia". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00003075. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*